Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells

Hemasphere. 2021 Feb 10;5(3):e533. doi: 10.1097/HS9.0000000000000533. eCollection 2021 Mar.

Philipp Karschnia^{1

2}, Felix Strübing³, Nico Teske^{1

2}, Viktoria Blumenberg^{2

4

5}, Veit L Bücklein^{2

4

5}, Christian Schmidt^{2

4}, Florian Schöberl⁶, Konstantinos Dimitriadis⁶, Robert Forbrig⁷, Hans-Joachim Stemmler^{2

4}, Joerg-Christian Tonn^{1

2}, Michael von Bergwelt-Baildon^{2

4}, Marion Subklewe^{2

4

5}, Louisa von Baumgarten^{1

2

6}

¹ Division of Neuro-Oncology, Department of Neurosurgery, Ludwig-Maximilians-University School of Medicine, Munich, Germany.
² German Cancer Consortium (DKTK), Partner Site Munich, Germany.
³ Center for Neuropathology and Prion Research, Ludwig-Maximilians-University School of Medicine, Munich, Germany.
⁴ Department of Medicine, Hematology & Oncology Division and Cellular Immunotherapy Program, Ludwig-Maximilians-University School of Medicine, Munich, Germany.
⁵ Laboratory for Translational Cancer Immunology, Gene Center of the Ludwig-Maximilians-University Munich, Munich, Germany.
⁶ Department of Neurology, Ludwig-Maximilians-University School of Medicine, Munich, Germany.
⁷ Department of Neuroradiology, Ludwig-Maximilians-University School of Medicine, Munich, Germany.

No abstract available

Publication types